Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.83B | 1.83B | 1.54B | 1.48B | 1.07B |
Gross Profit | 487.39M | 501.95M | 414.45M | 471.26M | 284.58M |
EBITDA | 160.68M | 53.50M | 237.57M | 266.08M | -97.78M |
Net Income | -203.70M | -194.21M | 49.52M | 75.07M | -258.45M |
Balance Sheet | |||||
Total Assets | 4.13B | 4.50B | 4.75B | 4.73B | 4.58B |
Cash, Cash Equivalents and Short-Term Investments | 1.40B | 1.24B | 1.20B | 1.89B | 1.82B |
Total Debt | 357.62M | 456.94M | 475.02M | 117.97M | 139.88M |
Total Liabilities | 746.56M | 881.82M | 896.09M | 504.94M | 456.51M |
Stockholders Equity | 2.98B | 3.24B | 3.49B | 3.86B | 3.81B |
Cash Flow | |||||
Free Cash Flow | 206.11M | 229.79M | -5.46M | 151.00M | 3.75M |
Operating Cash Flow | 244.83M | 247.53M | 31.73M | 170.95M | 39.05M |
Investing Cash Flow | 164.29M | -20.95M | 587.77M | -261.67M | -742.86M |
Financing Cash Flow | -235.72M | -151.07M | -518.45M | -90.80M | -93.68M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | 712.26M | 8.63 | 1.07% | 7.51% | 0.47% | 50.46% | |
68 Neutral | 1.67B | 5.75 | 22.09% | 4.29% | -3.56% | -17.45% | |
54 Neutral | HK$1.79B | ― | -4.66% | 0.45% | -0.55% | 45.36% | |
52 Neutral | 1.26B | 48.37 | 1.28% | ― | -4.30% | 13.83% | |
48 Neutral | 939.72M | 6.46 | 0.00% | ― | 2.30% | 0.00% | |
46 Neutral | 1.56B | -12.63 | -1.96% | 1.59% | -4.09% | -1242.31% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
Town Health International Medical Group Ltd. has updated its shareholders on the ongoing proceedings related to a profit guarantee concerning its acquisition of Central Medical Holdings Limited. The company identified HK$5,000,000 in transactions that should be excluded from the Target Group’s operational profit for the financial year ended 31 March 2023. Consequently, Town Health is claiming an additional HK$75,000,000 due to the non-satisfaction of the performance target, raising the total claim amount to HK$172,956,690. The proceedings are still ongoing, and the company will provide further updates as necessary.
The most recent analyst rating on (HK:3886) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Town Health International Medical Group Ltd. stock, see the HK:3886 Stock Forecast page.
Town Health International Medical Group Limited announced its interim financial results for the six months ended 30 June 2025, reporting a revenue of approximately HK$900.9 million and a net profit of approximately HK$35.6 million, a significant turnaround from the net loss of HK$28.5 million in the same period last year. The company maintained a strong financial position with net assets of approximately HK$3.44 billion and a stable current ratio of 3.19, while the gearing ratio improved to 0.38%. Despite these positive financial results, the Board decided not to recommend an interim dividend for the period.
The most recent analyst rating on (HK:3886) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Town Health International Medical Group Ltd. stock, see the HK:3886 Stock Forecast page.
Town Health International Medical Group Ltd. has updated its shareholders regarding the profit guarantee related to its acquisition of Central Medical Holdings Limited. The Target Group’s audited net profit for the financial year ended 31 March 2024 was HK$28,255,287, which is below the performance target of HK$30,000,000. After excluding certain transactions totaling HK$13,860,000 that were not directly attributable to operational activities, the adjusted net profit stands at HK$14,395,287. This shortfall implies that the seller parties are obliged to compensate the buyer as per the agreed formula, impacting the financial expectations and obligations of the involved parties.
The most recent analyst rating on (HK:3886) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Town Health International Medical Group Ltd. stock, see the HK:3886 Stock Forecast page.
Town Health International Medical Group Ltd. has announced that its board of directors will meet on August 29, 2025, to approve the unaudited interim results for the first half of the year and consider the payment of an interim dividend. This meeting is crucial for stakeholders as it will provide insights into the company’s financial health and potential returns.
The most recent analyst rating on (HK:3886) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Town Health International Medical Group Ltd. stock, see the HK:3886 Stock Forecast page.
Town Health International Medical Group Ltd. announced updates regarding the ongoing proceedings related to the profit guarantee for its acquisition of Central Medical Holdings Limited. The company is unable to disclose further details due to confidentiality, but will provide updates as appropriate. Additionally, Town Health has extended the timeline for utilizing unutilized First Net Proceeds from subscription shares and convertible preference shares until the end of 2026, due to the adverse impacts of COVID-19 and global economic slow-down on the healthcare industry.
Town Health International Medical Group Ltd. has issued a positive profit alert, indicating a significant turnaround in its financial performance for the first half of 2025. The company expects to report an unaudited consolidated profit of between HK$25.2 million and HK$39.6 million, a stark contrast to the loss recorded in the same period of 2024. This improvement is attributed to several factors, including a decrease in fair value loss on investment properties, no impairment losses on interests in associates, and a shift from recording losses to profits in its share of associates. The final results are still being finalized, and further adjustments may occur based on asset assessments.